Determination of substrate motifs for human Chk1 and hCds1/Chk2 by the oriented peptide library approach

被引:127
作者
O'Neill, T
Giarratani, L
Chen, P
Iyer, L
Lee, CH
Bobiak, M
Kanai, F
Zhou, BB
Chung, JH
Rathbun, GA
机构
[1] Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat,Ctr Blood Res, Boston, MA 02115 USA
[2] Agouron Pharmaceut Inc, San Diego, CA 92121 USA
[3] Harvard Univ, Sch Med, Ctr Res Comp, Boston, MA 02115 USA
[4] NIH, HLBI, Lab Biochem Genet, Bethesda, MD 20892 USA
[5] GlaxoSmithKline, Dept Oncol Res, King Of Prussia, PA 19406 USA
[6] Harvard Univ, Beth Israel Deaconess Hosp, Sch Med, Dept Med, Boston, MA 02115 USA
关键词
D O I
10.1074/jbc.M111705200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mammalian Chk1 and Chk2 are two Ser/Thr effector kinases that play critical roles in DNA damage-activated cell cycle checkpoint signaling pathways downstream of ataxia telangiectasia-mutated and ataxia telangiectasia-related. Endogenous substrates have been identified for human hCds1/Chk2 and Chk1; however, the sequences surrounding the substrate residues appear unrelated, and consensus substrate motifs for the two Ser/Thr kinases remain unknown. We have utilized peptide library analyses to develop specific, highly preferred substrate motifs for hCds1/Chk2 and Chk1. The optimal motifs are similar for both kinases and most closely resemble the previously identified Chk1 and hCds1/Chk2 substrate target sequences in Cdc25C and Cdc25A, the regulation of which plays an important role in S and G(2)M arrest. Essential residues required for the definition of the optimal motifs were also identified. Utilization of the peptides to assay the substrate specificities and catalytic activities of Chk1 and hCds1/Chk2 revealed substantial differences between the two Ser/Thr kinases. Structural modeling analyses of the peptides into the Chk1 catalytic cleft were consistent with Chk1 kinase assays defining substrate suitability. The library-derived substrate preferences were applied in a genome-wide search program, revealing novel targets that might serve as substrates for hCds1/Chk2 or Chk1 kinase activity.
引用
收藏
页码:16102 / 16115
页数:14
相关论文
共 94 条
  • [1] Ahn JY, 2000, CANCER RES, V60, P5934
  • [2] THE SAD1/RAD53 PROTEIN-KINASE CONTROLS MULTIPLE CHECKPOINTS AND DNA DAMAGE-INDUCED TRANSCRIPTION IN YEAST
    ALLEN, JB
    ZHOU, Z
    SIEDE, W
    FRIEDBERG, EC
    ELLEDGE, SJ
    [J]. GENES & DEVELOPMENT, 1994, 8 (20) : 2401 - 2415
  • [3] MOLECULAR-CLONING OF MEI-41, A GENE THAT INFLUENCES BOTH SOMATIC AND GERMLINE CHROMOSOME METABOLISM OF DROSOPHILA-MELANOGASTER
    BANGA, SS
    YAMAMOTO, AH
    MASON, JM
    BOYD, JB
    [J]. MOLECULAR & GENERAL GENETICS, 1995, 246 (02): : 148 - 155
  • [4] Enhanced phosphorylation of p53 by ATN in response to DNA damage
    Banin, S
    Moyal, L
    Shieh, SY
    Taya, Y
    Anderson, CW
    Chessa, L
    Smorodinsky, NI
    Prives, C
    Reiss, Y
    Shiloh, Y
    Ziv, Y
    [J]. SCIENCE, 1998, 281 (5383) : 1674 - 1677
  • [5] Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome
    Bell, DW
    Varley, JM
    Szydlo, TE
    Kang, DH
    Wahrer, DCR
    Shannon, KE
    Lubratovich, M
    Verselis, SJ
    Isselbacher, KJ
    Fraumeni, JF
    Birch, JM
    Li, FP
    Garber, JE
    Haber, DA
    [J]. SCIENCE, 1999, 286 (5449) : 2528 - 2531
  • [6] Besset V, 1998, MOL REPROD DEV, V50, P18, DOI 10.1002/(SICI)1098-2795(199805)50:1&lt
  • [7] 18::AID-MRD3&gt
  • [8] 3.0.CO
  • [9] 2-#
  • [10] Besset V, 1999, CELL GROWTH DIFFER, V10, P173